Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00433225 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00433225 is a Phase 4 study that has completed, run by Innovative Medical.
The verdict
NCT00433225, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.
Interventions
- DRUG Prednisolone Acetate
- DRUG Ketorolac 0.4%
- DRUG Gatifloxacin 0.3%
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00433225
The ClinicalTrials.gov registry entry for NCT00433225 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Prednisolone Acetate is the first listed.
NCT00433225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00433225 about?
NCT00433225 is a clinical study titled "Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation". The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.
What is the current status of trial NCT00433225?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00433225?
The interventions under investigation include: Prednisolone Acetate (DRUG), Ketorolac 0.4% (DRUG), Gatifloxacin 0.3% (DRUG).
Who is sponsoring clinical trial NCT00433225?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.